Intuitive Surgical (NASDAQ:ISRG) Reaches New 52-Week High After Analyst Upgrade

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRGGet Free Report) hit a new 52-week high on Friday after Evercore ISI raised their price target on the stock from $475.00 to $490.00. Evercore ISI currently has an in-line rating on the stock. Intuitive Surgical traded as high as $516.36 and last traded at $514.48, with a volume of 775960 shares traded. The stock had previously closed at $473.73.

Other research analysts have also recently issued research reports about the stock. Piper Sandler reissued an “overweight” rating and issued a $538.00 target price (up previously from $495.00) on shares of Intuitive Surgical in a report on Friday. Morgan Stanley raised their target price on shares of Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research report on Monday, July 15th. Barclays boosted their target price on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research note on Thursday, July 18th. Leerink Partners increased their price target on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday. Finally, Royal Bank of Canada boosted their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research report on Friday. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $503.75.

View Our Latest Stock Report on ISRG

Insider Activity

In related news, SVP Henry L. Charlton sold 40,243 shares of the business’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the transaction, the senior vice president now owns 3,001 shares in the company, valued at $1,461,006.84. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the sale, the senior vice president now owns 3,001 shares of the company’s stock, valued at $1,461,006.84. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Mark Brosius sold 2,115 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $491.91, for a total value of $1,040,389.65. Following the completion of the transaction, the insider now directly owns 295 shares in the company, valued at approximately $145,113.45. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 53,120 shares of company stock valued at $25,528,753. 0.90% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Ullmann Wealth Partners Group LLC boosted its position in shares of Intuitive Surgical by 1.6% during the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock worth $653,000 after purchasing an additional 21 shares in the last quarter. One Wealth Management Investment & Advisory Services LLC grew its stake in Intuitive Surgical by 3.4% in the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock valued at $310,000 after acquiring an additional 23 shares during the period. Daymark Wealth Partners LLC increased its holdings in shares of Intuitive Surgical by 0.3% during the third quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider’s stock valued at $3,452,000 after acquiring an additional 24 shares in the last quarter. Indiana Trust & Investment Management CO raised its position in shares of Intuitive Surgical by 5.3% during the second quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock worth $222,000 after purchasing an additional 25 shares during the period. Finally, Hoxton Planning & Management LLC lifted its holdings in shares of Intuitive Surgical by 4.9% in the 2nd quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock worth $238,000 after purchasing an additional 25 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Trading Up 10.0 %

The firm has a market cap of $184.85 billion, a price-to-earnings ratio of 94.07, a P/E/G ratio of 5.40 and a beta of 1.39. The firm’s 50-day moving average is $483.85 and its 200-day moving average is $437.79.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last issued its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The firm had revenue of $2.01 billion during the quarter, compared to analysts’ expectations of $1.97 billion. During the same period last year, the company earned $1.18 earnings per share. The business’s revenue was up 14.5% on a year-over-year basis. Analysts forecast that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Further Reading

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.